Award
Delivery Order #SPE2D326F7787
Delivery Order for Ondansetron Tablets under Military Pharmaceutical Contract
Buyer
Defense Logistics Agency
Award Amount
$220.32
Ceiling
$220.32
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 12, 2026
Identifier
SPE2D326F7787
NAICS
325411
This award is a delivery order contract executed under an existing indefinite delivery contract with Chartwell RX LLC, a pharmaceutical manufacturer and distributor specializing in military medical supplies. The contract procures Ondansetron ODT 4 mg tablets, a critical medication used to prevent nausea and vomiting, essential for military healthcare operations. This delivery order highlights the ongoing effort to support the U.S. military's medical readiness by ensuring consistent availability of vital pharmaceuticals. The scope includes delivering a specified quantity of Ondansetron tablets to fulfill immediate medical needs at designated locations. The contract was awarded based on the existing indefinite delivery contract without additional competitive bidding, reflecting the importance of timely access to these medications. The delivery order covers a short performance period in the near term, complementing the multi-year overarching agreement that facilitates continuous supply of essential drugs for military use.
Description
4571117532!ONDANSETRON ODT 4 MG TABLET 30S